Young Medical Cannabis Patients More Likely to Experience Withdrawal Symptoms, Finds Study
Following a two-year longitudinal study, the researchers concluded that cannabis withdrawal should be considered on a scale of severity, rather than as distinct subtypes of withdrawal syndromes.
Add-on CBD Reduces Seizures in Patients With Tuberous Sclerosis, Study Finds
The clinical trial found that Epidiolex can reduce the number of seizures in patients with tuberous sclerosis complex (TSC) by around 50 percent, compared to baseline levels.
A Brief History of Psychedelic Research With Albert Garcia-Romeu
Albert Garcia-Romeu, an assistant professor at the Center for Psychedelic and Consciousness Research at Johns Hopkins University, walks Analytical Cannabis through the past, present, and future of psychedelic research.
Cannabis Reduces Stress in Female Rats, Study Finds
Female rats, who had been trained to inhale cannabis vapor daily, developed a blunted psychological response to stress, according to new research out of Washington State University.
DEA Adds New Rule to Encourage Cannabis Research
The long-awaited rule should improve the quantity, quality, and accessibility of cannabis for scientific researchers in the US.
Medical Cannabis Can Reduce Epileptic Seizures By 97 Percent, Study Finds
In a new study of 10 patients, researchers from Imperial College London found that a combination of CBD and THC treatments can be effective in seizure control where CBD alone is not.
New Colorado Regulations for the Measurement of Heavy Metals in Cannabis Vaping Aerosols, A Realistic and Practical Assessment: Part 3
We discuss the ICP-MS measurement technique and the many potential sources of interferences observed when determining the most common metals found in aerosols generated from organic-rich vaping liquids.
The Top 10 Cannabis Stories of 2020
The year unlike any other has challenged just about every sector of society, but cannabis businesses, research centers and reform groups have still managed to make impressive headway.
Cannabinoids Could Limit Brain Injury Damage, Say Researchers
Analytical Cannabis speaks to a research group from the Medical College of Georgia at Augusta University, who have been awarded a $1.8 million grant to investigate how the body’s endocannabinoid system might potentially limit the secondary damages caused by brain damage inflammation.
